Neurology

Sleep Duration Linked to Cognitive Decline for Geriatric Individuals

September 22, 2020

Those who slept more than 10 hours or less than 4 hours per night declined faster than those who slept about 7 hours per night.

New Medication Helps Improve Multiple Alzheimer Disease Biomarkers

September 19, 2020

Sumifilam could be the first Alzheimer treatment to improve several biomarkers.

Tranexamic Acid Shows No Symptom Benefit for Traumatic Brain Injuries

September 16, 2020

Favorable neurologic function was slightly higher in a tranexamic acid group than patients taking a placebo.

Majority of Youth Fully Recover 1 Year Post-Concussion

August 27, 2020

Youth with repeat concussion have worse outcomes and more delays returning to normal life.

Traumatic Brain Injuries Linked to Sleep, Fatigue Problems

August 25, 2020

Approximately 50% of patients with a mTBI who experience fatigue or sleep-wake disturbances 2 weeks following the injury continue to have problems at the 3 month mark.

Laryngeal Movement Disorders Distinguish MSA from Parkinson Disease

August 22, 2020

Considerable discrepancy found between overt clinical symptoms of laryngeal pathology and abnormalities observed during a task protocol.

FDA Approves New Neuromyelitis Optica Spectrum Disorder Treatment

August 17, 2020

Satralizumab represents only the second targeted treatment for NMOSD and the first cleared for at-home administration.

FDA Approves Viltolarsen for Duchenne Muscular Dystrophy

August 12, 2020

The approval is based on findings from a phase 2 clinical trial.

Naahaad Mukadam, PhD: Addressing the Dementia Public Health Crisis

August 10, 2020

A team of researchers have added 3 new modifiable risk factors to a list of 9 known factors that increase the risk of developing dementia.

FDA Sets PDUFA Date on Aducanumab for Alzheimer Disease

August 07, 2020

Investigators found a 22% reduction in clinical decline at the 78-week cutoff in the intent to treat population in EMERGE who received high-dose aducanumab, with a similar reduction seen in the opportunity to complete population.